359 reports of this reaction
2.3% of all FEXOFENADINE HCL reports
#8 most reported adverse reaction
PRURITUS is the #8 most commonly reported adverse reaction for FEXOFENADINE HCL, manufactured by CVS Pharmacy. There are 359 FDA adverse event reports linking FEXOFENADINE HCL to PRURITUS. This represents approximately 2.3% of all 15,768 adverse event reports for this drug.
Patients taking FEXOFENADINE HCL who experience pruritus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRURITUS is a less commonly reported adverse event for FEXOFENADINE HCL, but still significant enough to appear in the safety profile.
In addition to pruritus, the following adverse reactions have been reported for FEXOFENADINE HCL:
The following drugs have also been linked to pruritus in FDA adverse event reports:
PRURITUS has been reported as an adverse event in 359 FDA reports for FEXOFENADINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRURITUS accounts for approximately 2.3% of all adverse event reports for FEXOFENADINE HCL, making it a notable side effect.
If you experience pruritus while taking FEXOFENADINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.